Chen Chaoxing, Zhao Shishi, Chen Zhengjie, He Yuting, Chen Jiali, Zheng Liangyu, Xia Yun, Papadimos Thomas J, Shi Kejian, Chen Hongfei, Liu Le, Xu Xuzhong, Jin Zhousheng, Wang Quanguang
Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Department of Anesthesiology, the Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Clin Toxicol (Phila). 2025 Jul;63(7):507-517. doi: 10.1080/15563650.2025.2510528. Epub 2025 Jun 4.
Abnormal energy metabolism is an important mechanism in the development of bupivacaine-induced cardiotoxicity. Apelin, a peptide derived from adipocytes, plays a pivotal role in both energy metabolism and the regulation of the cardiovascular system, thereby potentially linking it to bupivacaine-induced cardiotoxicity.
Our study employed both an Sprague-Dawley neonatal rat cardiomyocyte-based bupivacaine toxicity model and an bupivacaine-induced adult male Sprague-Dawley rat asystole model. Beating frequency ratio, survival rate and oxygen consumption rate were assessed, and changes in mitochondrial ultrastructure were examined. The expression of adenosine monophosphate-activated protein kinase, acetyl coenzyme-A carboxylase, and peroxisome proliferator-activated receptor-gamma coactivator-1α were quantified.
Exogenous [Pyr]apelin-13 22 μmol/L improved bupivacaine-induced 90 μmol/L inhibition of the cardiomyocyte beating frequency ratio (mean difference 0.48; 95% CI: 0.35-0.62; .001; = 5) after a 20 min exposure. [Pyr]apelin-13 also preserved mitochondrial ultrastructure, modulated oxygen consumption rate, and these protective effects were nullified by apelin receptor short hairpin ribonucleic acid. Exogenous [Pyr]apelin-13 0.15 mg/kg improved the survival rate in adult male rats with bupivacaine-induced 30 mg/kg asystole (12/12 [100%] versus 6/12 [50%]; = 0.014), while the presence of the specific apelin receptor antagonist Phe13-Ala, at an equivalent dose abolished this benefit (3/12 [25%]). Additionally, apelin treatment was associated with upregulation of metabolic proteins, including adenosine monophosphate-activated protein kinase, acetyl coenzyme-A carboxylase, and peroxisome proliferator-activated receptor-gamma coactivator-1α in the heart tissue over a 60 min period.
Despite apelin being identified initially as the sole apelin receptor ligand, evidence shows distinct effects between apelin and apelin receptor knockout models, as well as Phe13-Ala and adenovirus-mediated apelin receptor interventions. We confirmed that the cardioprotective effects of apelin depend on apelin receptor interaction.
Exogenous [Pyr]apelin-13 reversed bupivacaine-induced cardiotoxicity in adult male Sprague-Dawley rats and neonatal cardiomyocytes via modulation of mitochondrial structure and function, mediated through the apelin receptor.
能量代谢异常是布比卡因诱导心脏毒性发生发展的重要机制。Apelin是一种源自脂肪细胞的肽,在能量代谢和心血管系统调节中均发挥关键作用,因此可能与布比卡因诱导的心脏毒性相关。
我们的研究采用了基于Sprague-Dawley新生大鼠心肌细胞的布比卡因毒性模型以及布比卡因诱导的成年雄性Sprague-Dawley大鼠心搏停止模型。评估了搏动频率比、存活率和氧消耗率,并检测了线粒体超微结构的变化。对单磷酸腺苷激活蛋白激酶、乙酰辅酶A羧化酶和过氧化物酶体增殖物激活受体γ共激活因子-1α的表达进行了定量分析。
在暴露20分钟后,外源性22 μmol/L的[Pyr]apelin-13改善了布比卡因诱导的90 μmol/L对心肌细胞搏动频率比的抑制作用(平均差异0.48;95%置信区间:0.35 - 0.62;P <.001;n = 5)。[Pyr]apelin-13还保留了线粒体超微结构,调节了氧消耗率,并且这些保护作用被apelin受体短发夹核糖核酸消除。外源性0.15 mg/kg的[Pyr]apelin-13提高了布比卡因诱导的30 mg/kg心搏停止成年雄性大鼠的存活率(12/12 [100%] 对 6/12 [50%];P = 0.014),而同等剂量的特异性apelin受体拮抗剂Phe13-Ala的存在则消除了这种益处(3/12 [25%])。此外,在60分钟内,apelin治疗与心脏组织中包括单磷酸腺苷激活蛋白激酶、乙酰辅酶A羧化酶和过氧化物酶体增殖物激活受体γ共激活因子-1α在内的代谢蛋白上调有关。
尽管Apelin最初被确定为唯一的apelin受体配体,但有证据表明apelin与apelin受体基因敲除模型以及Phe13-Ala和腺病毒介导的apelin受体干预之间存在不同的效应。我们证实了apelin的心脏保护作用取决于apelin受体相互作用。
外源性[Pyr]apelin-13通过调节线粒体结构和功能,经由apelin受体介导,逆转了布比卡因诱导的成年雄性Sprague-Dawley大鼠和新生心肌细胞的心脏毒性。